Loading the state's markets…
Loading the state's markets…
Loading the market…
Medicare market size, surgeons and outlook to 2030
Medicare fee-for-service cochlear implants cases in North Carolina: reported (2020, the pandemic year, left out of the line), then forecast with its 80% range. One year ahead, this procedure’s market forecast has been off by 23% on average (17 state-years, 2020–2024): small markets swing, so treat it as rough.
| Year | Surgeons | Medicare FFS | Advantage share |
|---|---|---|---|
| 2019 | 2 | 120 | 40% |
| 2020 | 2 | 120 | 43% |
| 2021 | 3 | 140 | 48% |
| 2022 | 3 | 144 | 52% |
| 2023 | 5 | 188 | 56% |
| 2024 | 5 | 192 | 59% |
| 2025 from claims | – | 196 159–230 | 61% |
| 2026 forecast | – | 214 167–268 | 62% |
| 2027 forecast | – | 232 172–307 | 62% |
| 2028 forecast | – | 252 178–347 | 63% |
| 2029 forecast | – | 273 186–391 | 64% |
| 2030 forecast | – | 296 194–439 | 65% |
Cochlear implantation, children and adults. Professional codes (what the surgeon bills): CPT 69930.
Surgeons and fee-for-service cases are from CMS’s Medicare Physician & Other Practitioners files, counted where the surgeon billed; state totals include the cases CMS leaves out of the surgeon-level file (under 11 patients). All Medicare adds patients in Medicare Advantage at the state’s enrollment share; all payers scales Medicare by its share of the procedure nationally. The forecast carries cases per resident 65+ forward with the Census projection of residents 65+. How the numbers are made · Data sources
The 10 busiest do 100% of the cases CMS names in North Carolina; 4 surgeons do 80% of them.
MedaRep names every one, ranked by volume, with their practice, hospitals, trend, forecast and which device companies already engage with them.
In 2025, 79% hospital outpatient, 21% surgery center. The share outside the hospital has moved −21 pts since 2022.
| State | Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast |
|---|---|---|---|---|---|---|
| Florida | 9 | 349+4.4%/yr | +4.4%/yr | 0.2 | 30% | 300 in 2030−2.5%/yr |
| Texas | 9 | 288+1.6%/yr | +1.6%/yr | 0.1 | 13% | 330 in 2030+2.2%/yr |
| Tennessee | 7 | 205+8.7%/yr | +8.7%/yr | 0.3 | 28% | 290 in 2030+6.2%/yr |
| South Carolina | 6 | 142+4.7%/yr | +4.7%/yr | 0.2 | 17% | 310 in 2030+14%/yr |
| Georgia | 4 | 121+12%/yr | +12%/yr | 0.1 | 0% | 230 in 2030+11%/yr |
| Maryland | 4 | 116+2.8%/yr | +2.8%/yr | 0.1 | 0% | 100 in 2030−2.1%/yr |
| Virginia | 3 | 115+6.7%/yr | +6.7%/yr | 0.1 | 0% | 150 in 2030+4.4%/yr |
| Surgeons | Medicare FFS | Growth since 2019 | Per 1,000 | Out of hospital | Forecast | |
|---|---|---|---|---|---|---|
| Sinus surgery & balloon dilation | 39 | 3,683−8.4%/yr | −8.4%/yr | 3.80.7× | 87% | 4,040 in 2030+1.6%/yr |
| Ear tubes & middle ear surgery | 0 | 179−7.8%/yr | −7.8%/yr | 0.20.5× | 49% | 500 in 2030+19%/yr |
| Sleep apnea & airway implants | 6 | 178+96%/yr | +96%/yr | 0.20.7× | 0% | 270 in 2030+7%/yr |
Cochlear implants in every state, and its device makers · Every procedure market in North Carolina · Every state · Compare with Florida
Med-El leads with 71% of company spending on these surgeons in 2025, +14 pts on 2024.
In 2025, 8 companies reported engagement with North Carolina’s surgeons worth $57K in consulting, speaking, meals and travel tied to these products, about $11K per surgeon billing it. Royalties are left out.
FDA, last 12 months: 15 clearances and approvals in the category, 3 recalled product lines. A recall is a public FDA notice, not a finding of fault.
Which surgeons each company engages, and the dollars reported, are in the ranking. Open Payments shows the payments companies reported. It suggests engagement, not which devices a surgeon uses, and is not evidence of wrongdoing. Every company in the category.
Share of the cases CMS names by surgeon, by where they billed. Open one for its ranking.
For CPT 69930 (implant cochlear device), commercial plans pay North Carolina’s hospitals a median of $33K, from $33K at the lowest to $40K at the highest, across 8 hospitals that publish a price.
Each hospital’s median over its commercial plans, from the machine-readable files hospitals must post; not every hospital is loaded.